ROCKWELL MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ROCKWELL MEDICAL, INC. (RMTI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 4.95 thousand shares for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2019-11-12
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-09-30 was 1.30K shares.
- ROCKWELL MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-03-31 was 25.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month |
|---|---|---|---|
| 2019-09-30 | 1.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 4.95K shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 3.65K shares 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | 25.00K shares 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |